The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer

被引:22
作者
Lee, JM
Shun, CT
Wu, MT
Chen, YY
Yang, SY
Hung, HI
Chen, JS
Hsu, HH
Huang, PM
Kuo, SW
Lee, YC
机构
[1] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Forens Med & Pathol, Taipei, Taiwan
[3] Kauhsiung Med Univ, Grad Inst Occupat Hlth & Safety, Kauhsiung, Taiwan
[4] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10764, Taiwan
关键词
esophageal cancer; p53; polymorphism; overexpression; mutation; smoking; drinking; areca;
D O I
10.1016/j.mrfmmm.2005.09.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Variations in p53 codon 72 have been identified as significant predisposing factors for various cancers, but molecular mechanisms remain unclear. We investigated associations of p53 overexpression with codon 72 variants and other factors with esophageal cancer. Status of p53 overexpression was determined by inummohistochemical staining. Codon 72 polymorphisms and mutation of p53 was identified by PCR-RFLP and direct sequencing from exons 4 to 9, respectively. We evaluated 126 patients who underwent esophagectomy in the National Taiwan University Hospital, and found that the status of p53 overexpression was significantly influenced by presence of codon 72 polymorphisms. After adjustment for other possible confounders. the incidence of p53 overexpression was significantly decreased in patients with Pro/Pro genotype with an odds ratio (OR) of 0.21 (95% CI: 0.067-0.64) (p = 0.0065) compared with incidence in patients with Arg/Arg genotype. The incidence of p53 overexpression was additively increased with environmental exposure to cigarette smoke, alcohol, and areca quid. When compared with individuals exposed to only one of these environmental risk factors, patients who had exposure to two or three risk factors had ORs of 6.11 (95% CI: 1.80-20.75) and 6.22 (95% Cl: 1.81-21.34) for p53 overexpression, respectively. Elderly patients (age > 70 years) were also more likely to have p53 overexpression, with an OR of 5.63 (95% Cl: 1.53-20.64) compared with overexpression among patients aged less than 55 years. Forty-one patients received further evaluation of p53 mutation. There was also a higher incidence of, but without reaching a statistical significance, p53 mutation in patients with p53 overexpression (OR[95% Cl]: 2.18 [0.52-9.6]) and codon 72 Arg/Arg genotype (OR [95% Cl] of 0.8 [0.13-4.2], comparing genotypes of Pro/Pro and Arg/Pro with Arg/Arg). Our data provide the first observations that the presence of p53 codon 72 variants can be a significant factor influencing p53 overexpression in esophageal cancer, with overexpression also influenced by combined or prolonged environmental exposures. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:181 / 188
页数:8
相关论文
共 42 条
[31]  
SCHOTTENFELD D, 1984, SEMIN ONCOL, V11, P92
[32]  
Shao ZM, 2001, CLIN CANCER RES, V7, P2222
[33]   Histological response of cisplatin predicts patients' survival in oesophageal cancer and p53 protein accumulation in pretreatment biopsy is associated with cisplatin sensitivity [J].
Shimada, Y ;
Watanabe, G ;
Yamasaki, S ;
Maeda, M ;
Kawabe, A ;
Kaganoi, JI ;
Itami, A ;
Fukumoto, M ;
Kanda, Y ;
Imamura, M .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (08) :987-993
[34]   p53 polymorphisms and haplotypes in breast cancer [J].
Sjalander, A ;
Birgander, R ;
Hallmans, G ;
Cajander, S ;
Lenner, P ;
Athlin, L ;
Beckman, G ;
Beckman, L .
CARCINOGENESIS, 1996, 17 (06) :1313-1316
[35]   The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry [J].
Sjogren, S ;
Inganas, M ;
Norberg, T ;
Lindgren, A ;
Nordgren, H ;
Holmberg, L ;
Bergh, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (3-4) :173-182
[36]   Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization grade II astrocytoma or oligoastrocytoma -: A long-term analysis [J].
Ständer, M ;
Peraud, A ;
Leroch, B ;
Kreth, FW .
CANCER, 2004, 101 (05) :1028-1035
[37]   Role of a p53 polymorphism in the development of human papillomavirus-associated cancer [J].
Storey, A ;
Thomas, M ;
Kalita, A ;
Harwood, C ;
Gardiol, D ;
Mantovani, F ;
Breuer, J ;
Leigh, IM ;
Matlashewski, G ;
Banks, L .
NATURE, 1998, 393 (6682) :229-234
[38]   Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo [J].
Sullivan, A ;
Syed, N ;
Gasco, M ;
Bergamaschi, D ;
Trigiante, G ;
Attard, M ;
Hiller, L ;
Farrell, PJ ;
Smith, P ;
Lu, X ;
Crook, T .
ONCOGENE, 2004, 23 (19) :3328-3337
[39]  
Thomas M, 1999, MOL CELL BIOL, V19, P1092
[40]   Risk of betel chewing for oesophageal cancer in Taiwan [J].
Wu, MT ;
Lee, YC ;
Chen, CJ ;
Yang, PW ;
Lee, CJ ;
Wu, DC ;
Hsu, HK ;
Ho, CK ;
Kao, EL ;
Lee, JM .
BRITISH JOURNAL OF CANCER, 2001, 85 (05) :658-660